JDOCvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with JDOC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC ETF 2 | +4.30%– | +2.92%– | +10.60%– | +16.91%– | +33.69%– | n/a– |
| Flows | JDOC ETF 2 | -– | -– | -$34K– | -$34K– | +$7M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC ETF 2 | +15.74%– | +15.54%– | +14.83%– | n/a– |
| Max drawdown | JDOC ETF 2 | -7.92%– | -9.66%– | -24.04%– | n/a– |
| Max drawdown duration | JDOC ETF 2 | 64d– | 154d– | 704d– | n/a– |
Trading data
JDOC | ETF 2 | |
Last sale 10/29/2026 at 1:30 PM | $65.34 | – |
| Previous close 10/28/2026 | $64.05 | – |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
JDOC | ETF 2 | |
|---|---|---|
| Last price | $65.34 | – |
| 1D performance | +2.03% | – |
| AuM | $9.60 M | – |
| E/R | 0.65% | – |
Characteristics
JDOC | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | J.P. Morgan Asset Management | – |
| Benchmark | - | – |
| N° of holdings | 57 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
JDOC
USA
73.86%
Other
26.14%
ETF 2
Sectors
JDOC
Healthcare
96.33%
Other
3.67%
ETF 2
Advertisement
Diversification
JDOC
Total weight of top 15 holdings out of 15
59.39%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
JDOC
AbbVie, Inc.
7.91%
Eli Lilly & Co.
7.63%
Merck & Co., Inc.
5.32%
Johnson & Johnson
4.80%
Thermo Fisher Scientific, Inc.
4.15%
UnitedHealth Group, Inc.
3.64%
Bristol Myers Squibb Co.
3.52%
AstraZeneca PLC
3.48%
Abbott Laboratories
3.15%
Novo Nordisk A/S
2.95%
Roche Holding AG
2.80%
argenx SE
2.79%
Danaher Corp.
2.56%
GSK Plc
2.47%
CVS Health Corp.
2.24%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
